SYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine Products
21 janv. 2021 16h05 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that its SYMJEPI® (epinephrine) Injection products are now available to members of the...
Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19
20 janv. 2021 09h00 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today the submission of an Investigational New Drug (IND) to FDA for the...
Adamis Pharmaceuticals Describes Planned Response to ZIMHI Complete Response Letter
01 déc. 2020 09h00 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced a planned response to a Complete Response Letter (CRL) from the U.S. Food and Drug...
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI
16 nov. 2020 06h45 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today announced that after the close of business and the U.S. markets on November 13th, it...
Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update
09 nov. 2020 16h30 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the third quarter ended September 30, 2020 and provided a...
Adamis Pharmaceuticals Schedules Third Quarter 2020 Results Conference Call and Business Update
05 nov. 2020 09h00 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today that it will host an investor conference call on Monday, November 9,...
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
18 sept. 2020 09h00 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various...
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
17 sept. 2020 16h05 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various...
Adamis Pharmaceuticals Provides Update on Annual Meeting of Stockholders
03 sept. 2020 16h05 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced the results of its reconvened 2020 annual meeting of stockholders which was initially...
Adamis Pharmaceuticals Provides Update on Annual Meeting of Stockholders and Proposals
25 août 2020 09h00 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided additional information concerning the proposals to be considered at its adjourned 2020...